1. Development of a label-free gold nanoparticle-based colorimetric aptasensor for detection of human estrogen receptor alpha
   Rajesh Ahirwar et al, 2016, Analytical and Bioanalytical Chemistry CrossRef
2. Recent advances in predicting lncRNA–disease associations based on computational methods
   Jing Yan et al, 2023, Drug Discovery Today CrossRef
3. Novel off-target effect of tamoxifen — Inhibition of acid ceramidase activity in cancer cells
   Samy A.F. Morad et al, 2013, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids CrossRef
4. Selective Estrogen Receptor Modulators (SERMs) for the treatment of ER+ breast cancer: An overview
   Sweety Das et al, 2022, Journal of Molecular Structure CrossRef
5. Toremifene for Breast Cancer: A Review of 20 Years of Data
   Charles L. Vogel et al, 2014, Clinical Breast Cancer CrossRef
6. In silico selection of an aptamer to estrogen receptor alpha using computational docking employing estrogen response elements as aptamer-alike molecules
   Rajesh Ahirwar et al, 2016, Scientific Reports CrossRef
7. Label-free detection of anti-estrogen receptor alpha and its binding with estrogen receptor peptide alpha by terahertz spectroscopy
   Mingliang Li et al, 2017, RSC Advances CrossRef
8. The selective estrogen receptor modulator raloxifene mitigates the effect of all-trans-retinal toxicity in photoreceptor degeneration
   Tamar Getter et al, 2019, Journal of Biological Chemistry CrossRef
9. Aptamer-Assisted Detection of the Altered Expression of Estrogen Receptor Alpha in Human Breast Cancer
   Rajesh Ahirwar et al, 2016, PLOS ONE CrossRef
10. A Computational Framework to Infer Human Disease-Associated Long Noncoding RNAs
    Ming-Xi Liu et al, 2014, PLoS ONE CrossRef
11. High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases
    Ryutaro Mori et al, 2014, Case Reports in Oncology CrossRef
12. Toremifene in the treatment of breast cancer
    Mika VJ Mustonen, 2014, World Journal of Clinical Oncology CrossRef
13. High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors
    Atsushi Fushimi et al, 2020, International Journal of Breast Cancer CrossRef
14. Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report
    Haruko Takuwa et al, 2018, BMC Cancer CrossRef